Diuretics as a basis of antihypertensive therapy: An overview

Drugs

Volumn 59, Issue SUPPL. 2, 2000, Pages 21-25

  Kaplan, Norman M ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INDAPAMIDE; LOOP DIURETIC AGENT; METOLAZONE; TORASEMIDE;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG CHOICE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; NATRIURESIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; SODIUM RETENTION; SUSTAINED RELEASE FORMULATION;

EID: 0033979632     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200059002-00003     Document Type: Review

References (30)

1. Neaton JD, Grimm Jr RH, Prineas RJ, et al. Treatment of mild hypertension study (TOMHS): final results. JAMA 1993; 270: 713-24
2. Materson BJ, Reda DJ, Cushman WC. Department of Veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. Am J Hypertens 1995; 8: 189-92
3. Frishman WH, Bryzinski BS, Coulson LR, et al. A multifactorial trial design to assess combination therapy in hypertension. Arch Intern Med 1994; 154: 1461-8
4. Townsend RR, Holland OB. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension. Arch Intern Med 1990; 150: 1174-83
5. Meyrier A, Dratwa M, Sennesael J, et al. Fixed low-dose perindopril-indapamide combination with hypertensive patients with chronic renal failure. Am J Hypertens 1998; 11: 1087-92
6. Flack JM. Evidence for the efficacy of low-dose diuretic monotherapy. Am J Med 1996; 101 (3A): 53S-60
7. Ambrosioni E, Safar M, Degaute J-P, et al. Low-dose antihypertensive therapy with 1.5 mg sustained-release indapamide: results of randomised double-blind controlled studies. Am J Nephrol 1995; 15: 251-5
8. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 266; 3255-64
9. Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish Trial in old patients with hypertension (STOP-Hypertension). Lancet 338: 1281-5
10. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ 1992; 304: 405-12
11. Curb JD, Pressel SL, Cutler JA, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996; 9: 828-32
12. Siscovick DS, Raghunathan TE, Psaty BM, et al. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994; 330: 1852-7
13. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents. JAMA 1997; 277: 739-45
14. Madkour H, Gadallah M, Riveline B, et al. Comparison between the effects of indapamide and hydrochlorothiazide on creatinine clearance in patients with impaired renal function and hypertension. Am J Nephrol 1995; 15: 251-5
15. Lacourcière Y, Provencher P. Comparative effects of zofenopril and hydrochlorothiazide on office and ambulatory blood pressures in mild to moderate essential hypertension. Br J Clin Pharmacol 1989; 27: 371-6
16. Omvik P, Tarazi ED, Bravo EL. Regulation of sodium balance in hypertension. Hypertension 1980; 2: 515-23
17. Finnerty Jr FA, Davidov M, Mroczek WJ, et al. Influence of extracellular fluid volume on response to antihypertensive drugs. Circ Res 1970; 26 Suppl. 1: 71-80
18. Manning G, Miller-Craig MW. Review: calcium antagonists and diuretics; a useful combination in the management of hypertension? J Hum Hypertens 1996; 10: 441-2
19. Woodwell DA. National ambulatory medical care survey: 1996 summary: In: Advance data from vital and health statistics. No. 295. Hyattsville, MD: National Center for Health Statistics, 1997
20. Anderson J, Godfrey BE, Hill DM, et al. A comparison of the effects of hydrochlorothiazide and of furosemide in the treatment of hypertensive patients. Q J Med 1971; 40: 541-60
21. Wilcox CS, Mitch WE, Kelly RA, et al. Response of the kidney to furosemide I: effects of salt intake and renal compensation. J Lab Clin Med 1983; 102 (3): 450-8
22. Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Intern Med 1991; 151: 1786-92
23. Paton RR, Kane RE. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome. J Clin Pharm 1977; 17: 243-51
24. Dunn CJ, Fitton A, Brogden RN. Torasemide. An update of its pharmacological properties and therapeutic efficacy. Drugs 1995; 49: 121-42
25. Joint National Committee. The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 158: 2413-46
26. Guidelines Subcommitte. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17: 151-83
27. Leonetti G. Clinical positioning of indapamide sustained release 1.5mg in management protocols for hypertension. Drugs 2000; 59 Suppl. 2: 27-38
28. Walma EP, Hoes AW, van Dooren C, et al. Withdrawal of long term diuretic medication in elderly patients: a double blind randomised trial. BMJ 1997; 315: 464-8
29. Grimm Jr RH, Grandits GA, Prineas RJ, et al. Long term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment of hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension 1997; 29: 8-14
30. Leonetti G, Rappelli A, Salvetti A, et al. Tolerability and well-being with indapamide in the treatment of mild-moderate hypertension. An Italian multicenter study. Am J Med 1988; 84 (1B): 59-64